[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100598336":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":19,"responsibleParty":48,"collaborators":50,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":56,"sex":62,"minAge":7,"maxAge":7,"enrollmentInfo":63,"targetDuration":7,"studyType":66,"phases":7,"briefSummary":67,"conditions":68,"keywords":71,"overallStatus":73,"whyStopped":7,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Chiesi Poland Sp. z o.o.","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DRUG","Intratracheal administration of surfactant","Intratracheal administration of pulmonary surfactant with any of the approved methods: (a) via endotracheal tube in a mechanically-ventilated infant, (b) with the INSURE method (intubation-surfactant-extubation), or (c) with LISA method (through a thin catheter inserted intratracheally in a spontaneously breathing infant, supported with CPAP)",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Piotr Kruczek, MD, PhD","CONTACT","+48 12 634 2601","kruczekpiotr@poczta.onet.pl",[20,35],{"facility":21,"status":7,"city":22,"state":7,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Department of Neonatology, Czerwiakowski Hospital at Siemiradzki st., Cracow, Poland","Krakow","31137","Poland","PL",{"type":27,"coordinates":28},"Point",[29,30],19.93658,50.06143,{"lat":30,"lon":29},[33],{"name":15,"role":16,"phone":34,"phoneExt":7,"email":18},"+48 12 512 301 447",{"facility":36,"status":7,"city":37,"state":7,"zip":7,"country":24,"countryCode":25,"cosmosGeoPoint":38,"geoPoint":42,"contacts":43},"Department of Neonatology and Neonatal Intensive Care, Medical University of Warsaw","Warsaw",{"type":27,"coordinates":39},[40,41],21.01178,52.22977,{"lat":41,"lon":40},[44],{"name":45,"role":16,"phone":46,"phoneExt":7,"email":47},"Renata Bokiniec, Prof.","+48 22 596 61 75","renata.bokiniec@wum.edu.pl",{"type":49,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[51],{"name":52,"class":53},"Polish Ultrasound Society, Neonatal Section","UNKNOWN","100598336","bedside-ultrasound-to-monitor-lung-function-and-blood-flow-in-newborns-treated-with-surfactant-100598336",false,"NCT07070167","Bedside Ultrasound to Monitor Lung Function and Blood Flow in Newborns Treated With Surfactant","Point-of-Care Ultrasonography for Assessing Lung Aeration and Pulmonary Vascular Resistance Dynamics After Surfactant Administration in Neonates With Respiratory Distress Syndrome","ULISSES","Inclusion Criteria:\n\n* Preterm neonates (gestational age \\\u003C37 weeks) with established Respiratory Distress Syndrome (RDS) or at risk for RDS\n* Decision of the use of surfactant by the attending physician\n\nExclusion Criteria:\n\n* Presence of major congenital abnormalities of the respiratory system\n* Infants requiring primary intubation and mechanical ventilation in the delivery room","ALL",{"count":64,"type":65},200,"ESTIMATED","OBSERVATIONAL","The ULISSES study looks at how doctors use bedside ultrasound to help treat premature babies with breathing problems caused by Respiratory Distress Syndrome (RDS). It focuses on whether doctors decide to give a medicine called surfactant based on oxygen levels alone or if they also use lung ultrasound images to guide their decision.\n\nAround 200 babies will take part in the study in hospitals across Poland. Doctors will do ultrasound scans of the babies' lungs before and after surfactant is given. In some hospitals, heart and lung blood flow will also be checked to look for signs of high blood pressure in the lungs.\n\nThe study will see if both lungs improve equally after treatment or if one side stays worse, and whether this affects how much breathing support the baby needs. The results may help doctors improve how and when they give surfactant, leading to better care for newborns with RDS.",[69,70],"Lung Ultrasound","Respiratory Distress Syndrome, Newborn",[72],"surfactant","NOT_YET_RECRUITING","2025-07-15",{"date":76,"type":77},"2025-07-17","ACTUAL",{"date":79,"type":65},"2025-08-30",{"date":81,"type":65},"2026-12-30",{"name":5,"class":6},2]